Global Anterior Horn Cell Disease Treatment Market Growth (Status and Outlook) 2022-2028
The procedure of achieving an accurate balance between the available feed ingredients is referred to as feed testing. The primary goal of the feed program is to reduce the level of contamination in animal feedstock. Feed ingredient nutrient content information is required for successful feed testing. Pesticides, mycotoxin, minerals, pathogens, metals, antibiotics, and drugs are tested in feed, among other feed ingredients, to determine the absence of contaminants that can cause toxicity, foodborne diseases, and poisoning.
The global market for Anterior Horn Cell Disease Treatment is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Anterior Horn Cell Disease Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Anterior Horn Cell Disease Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Anterior Horn Cell Disease Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Anterior Horn Cell Disease Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Anterior Horn Cell Disease Treatment players cover Sanofi, Novartis AG, Mitsubishi Chemical Group Corporation, BrainStorm Cell Limited and Ionis Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Anterior Horn Cell Disease Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Anterior Horn Cell Disease Treatment market, with both quantitative and qualitative data, to help readers understand how the Anterior Horn Cell Disease Treatment market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Anterior Horn Cell Disease Treatment market and forecasts the market size by Type (Riluzole, Edaravone and Glutamate Receptor Antagonist), by Application (Amyotrophic Lateral Sclerosis, Spinal Muscular Atrophy, Multifocal Motor Neuropathy and Other), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Riluzole
Edaravone
Glutamate Receptor Antagonist
Other
Segmentation by application
Amyotrophic Lateral Sclerosis
Spinal Muscular Atrophy
Multifocal Motor Neuropathy
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Sanofi
Novartis AG
Mitsubishi Chemical Group Corporation
BrainStorm Cell Limited
Ionis Pharmaceuticals
Genervon Biopharmaceuticals, LLC
Bausch Health Companies Inc
F. Hoffmann-La Roche Ltd
Treeway B.V
CYTOKINETICS
AB Science
ADVANZ PHARMA
Biogen
Orphazyme
KRIGLE PHARMA, INC
Aquestive Therapeutics, Inc
Apotex Inc
Chapter Introduction
Chapter 1: Scope of Anterior Horn Cell Disease Treatment, Research Methodology, etc.
Chapter 2: Executive Summary, global Anterior Horn Cell Disease Treatment market size and CAGR, Anterior Horn Cell Disease Treatment market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Anterior Horn Cell Disease Treatment revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Anterior Horn Cell Disease Treatment revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Anterior Horn Cell Disease Treatment market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Sanofi, Novartis AG, Mitsubishi Chemical Group Corporation, BrainStorm Cell Limited, Ionis Pharmaceuticals, Genervon Biopharmaceuticals, LLC, Bausch Health Companies Inc, F. Hoffmann-La Roche Ltd and Treeway B.V, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anterior Horn Cell Disease Treatment Market Size 2017-2028
2.1.2 Anterior Horn Cell Disease Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Anterior Horn Cell Disease Treatment Segment by Type
2.2.1 Riluzole
2.2.2 Edaravone
2.2.3 Glutamate Receptor Antagonist
2.2.4 Other
2.3 Anterior Horn Cell Disease Treatment Market Size by Type
2.3.1 Anterior Horn Cell Disease Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Anterior Horn Cell Disease Treatment Market Size Market Share by Type (2017-2022)
2.4 Anterior Horn Cell Disease Treatment Segment by Application
2.4.1 Amyotrophic Lateral Sclerosis
2.4.2 Spinal Muscular Atrophy
2.4.3 Multifocal Motor Neuropathy
2.4.4 Other
2.5 Anterior Horn Cell Disease Treatment Market Size by Application
2.5.1 Anterior Horn Cell Disease Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Anterior Horn Cell Disease Treatment Market Size Market Share by Application (2017-2022)
3 Anterior Horn Cell Disease Treatment Market Size by Player
3.1 Anterior Horn Cell Disease Treatment Market Size Market Share by Players
3.1.1 Global Anterior Horn Cell Disease Treatment Revenue by Players (2020-2022)
3.1.2 Global Anterior Horn Cell Disease Treatment Revenue Market Share by Players (2020-2022)
3.2 Global Anterior Horn Cell Disease Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Anterior Horn Cell Disease Treatment by Regions
4.1 Anterior Horn Cell Disease Treatment Market Size by Regions (2017-2022)
4.2 Americas Anterior Horn Cell Disease Treatment Market Size Growth (2017-2022)
4.3 APAC Anterior Horn Cell Disease Treatment Market Size Growth (2017-2022)
4.4 Europe Anterior Horn Cell Disease Treatment Market Size Growth (2017-2022)
4.5 Middle East & Africa Anterior Horn Cell Disease Treatment Market Size Growth (2017-2022)
5 Americas
5.1 Americas Anterior Horn Cell Disease Treatment Market Size by Country (2017-2022)
5.2 Americas Anterior Horn Cell Disease Treatment Market Size by Type (2017-2022)
5.3 Americas Anterior Horn Cell Disease Treatment Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anterior Horn Cell Disease Treatment Market Size by Region (2017-2022)
6.2 APAC Anterior Horn Cell Disease Treatment Market Size by Type (2017-2022)
6.3 APAC Anterior Horn Cell Disease Treatment Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Anterior Horn Cell Disease Treatment by Country (2017-2022)
7.2 Europe Anterior Horn Cell Disease Treatment Market Size by Type (2017-2022)
7.3 Europe Anterior Horn Cell Disease Treatment Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anterior Horn Cell Disease Treatment by Region (2017-2022)
8.2 Middle East & Africa Anterior Horn Cell Disease Treatment Market Size by Type (2017-2022)
8.3 Middle East & Africa Anterior Horn Cell Disease Treatment Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Anterior Horn Cell Disease Treatment Market Forecast
10.1 Global Anterior Horn Cell Disease Treatment Forecast by Regions (2023-2028)
10.1.1 Global Anterior Horn Cell Disease Treatment Forecast by Regions (2023-2028)
10.1.2 Americas Anterior Horn Cell Disease Treatment Forecast
10.1.3 APAC Anterior Horn Cell Disease Treatment Forecast
10.1.4 Europe Anterior Horn Cell Disease Treatment Forecast
10.1.5 Middle East & Africa Anterior Horn Cell Disease Treatment Forecast
10.2 Americas Anterior Horn Cell Disease Treatment Forecast by Country (2023-2028)
10.2.1 United States Anterior Horn Cell Disease Treatment Market Forecast
10.2.2 Canada Anterior Horn Cell Disease Treatment Market Forecast
10.2.3 Mexico Anterior Horn Cell Disease Treatment Market Forecast
10.2.4 Brazil Anterior Horn Cell Disease Treatment Market Forecast
10.3 APAC Anterior Horn Cell Disease Treatment Forecast by Region (2023-2028)
10.3.1 China Anterior Horn Cell Disease Treatment Market Forecast
10.3.2 Japan Anterior Horn Cell Disease Treatment Market Forecast
10.3.3 Korea Anterior Horn Cell Disease Treatment Market Forecast
10.3.4 Southeast Asia Anterior Horn Cell Disease Treatment Market Forecast
10.3.5 India Anterior Horn Cell Disease Treatment Market Forecast
10.3.6 Australia Anterior Horn Cell Disease Treatment Market Forecast
10.4 Europe Anterior Horn Cell Disease Treatment Forecast by Country (2023-2028)
10.4.1 Germany Anterior Horn Cell Disease Treatment Market Forecast
10.4.2 France Anterior Horn Cell Disease Treatment Market Forecast
10.4.3 UK Anterior Horn Cell Disease Treatment Market Forecast
10.4.4 Italy Anterior Horn Cell Disease Treatment Market Forecast
10.4.5 Russia Anterior Horn Cell Disease Treatment Market Forecast
10.5 Middle East & Africa Anterior Horn Cell Disease Treatment Forecast by Region (2023-2028)
10.5.1 Egypt Anterior Horn Cell Disease Treatment Market Forecast
10.5.2 South Africa Anterior Horn Cell Disease Treatment Market Forecast
10.5.3 Israel Anterior Horn Cell Disease Treatment Market Forecast
10.5.4 Turkey Anterior Horn Cell Disease Treatment Market Forecast
10.5.5 GCC Countries Anterior Horn Cell Disease Treatment Market Forecast
10.6 Global Anterior Horn Cell Disease Treatment Forecast by Type (2023-2028)
10.7 Global Anterior Horn Cell Disease Treatment Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Anterior Horn Cell Disease Treatment Product Offered
11.1.3 Sanofi Anterior Horn Cell Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Novartis AG
11.2.1 Novartis AG Company Information
11.2.2 Novartis AG Anterior Horn Cell Disease Treatment Product Offered
11.2.3 Novartis AG Anterior Horn Cell Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novartis AG Main Business Overview
11.2.5 Novartis AG Latest Developments
11.3 Mitsubishi Chemical Group Corporation
11.3.1 Mitsubishi Chemical Group Corporation Company Information
11.3.2 Mitsubishi Chemical Group Corporation Anterior Horn Cell Disease Treatment Product Offered
11.3.3 Mitsubishi Chemical Group Corporation Anterior Horn Cell Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Mitsubishi Chemical Group Corporation Main Business Overview
11.3.5 Mitsubishi Chemical Group Corporation Latest Developments
11.4 BrainStorm Cell Limited
11.4.1 BrainStorm Cell Limited Company Information
11.4.2 BrainStorm Cell Limited Anterior Horn Cell Disease Treatment Product Offered
11.4.3 BrainStorm Cell Limited Anterior Horn Cell Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 BrainStorm Cell Limited Main Business Overview
11.4.5 BrainStorm Cell Limited Latest Developments
11.5 Ionis Pharmaceuticals
11.5.1 Ionis Pharmaceuticals Company Information
11.5.2 Ionis Pharmaceuticals Anterior Horn Cell Disease Treatment Product Offered
11.5.3 Ionis Pharmaceuticals Anterior Horn Cell Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Ionis Pharmaceuticals Main Business Overview
11.5.5 Ionis Pharmaceuticals Latest Developments
11.6 Genervon Biopharmaceuticals, LLC
11.6.1 Genervon Biopharmaceuticals, LLC Company Information
11.6.2 Genervon Biopharmaceuticals, LLC Anterior Horn Cell Disease Treatment Product Offered
11.6.3 Genervon Biopharmaceuticals, LLC Anterior Horn Cell Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Genervon Biopharmaceuticals, LLC Main Business Overview
11.6.5 Genervon Biopharmaceuticals, LLC Latest Developments
11.7 Bausch Health Companies Inc
11.7.1 Bausch Health Companies Inc Company Information
11.7.2 Bausch Health Companies Inc Anterior Horn Cell Disease Treatment Product Offered
11.7.3 Bausch Health Companies Inc Anterior Horn Cell Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Bausch Health Companies Inc Main Business Overview
11.7.5 Bausch Health Companies Inc Latest Developments
11.8 F. Hoffmann-La Roche Ltd
11.8.1 F. Hoffmann-La Roche Ltd Company Information
11.8.2 F. Hoffmann-La Roche Ltd Anterior Horn Cell Disease Treatment Product Offered
11.8.3 F. Hoffmann-La Roche Ltd Anterior Horn Cell Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 F. Hoffmann-La Roche Ltd Main Business Overview
11.8.5 F. Hoffmann-La Roche Ltd Latest Developments
11.9 Treeway B.V
11.9.1 Treeway B.V Company Information
11.9.2 Treeway B.V Anterior Horn Cell Disease Treatment Product Offered
11.9.3 Treeway B.V Anterior Horn Cell Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Treeway B.V Main Business Overview
11.9.5 Treeway B.V Latest Developments
11.10 CYTOKINETICS
11.10.1 CYTOKINETICS Company Information
11.10.2 CYTOKINETICS Anterior Horn Cell Disease Treatment Product Offered
11.10.3 CYTOKINETICS Anterior Horn Cell Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 CYTOKINETICS Main Business Overview
11.10.5 CYTOKINETICS Latest Developments
11.11 AB Science
11.11.1 AB Science Company Information
11.11.2 AB Science Anterior Horn Cell Disease Treatment Product Offered
11.11.3 AB Science Anterior Horn Cell Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 AB Science Main Business Overview
11.11.5 AB Science Latest Developments
11.12 ADVANZ PHARMA
11.12.1 ADVANZ PHARMA Company Information
11.12.2 ADVANZ PHARMA Anterior Horn Cell Disease Treatment Product Offered
11.12.3 ADVANZ PHARMA Anterior Horn Cell Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 ADVANZ PHARMA Main Business Overview
11.12.5 ADVANZ PHARMA Latest Developments
11.13 Biogen
11.13.1 Biogen Company Information
11.13.2 Biogen Anterior Horn Cell Disease Treatment Product Offered
11.13.3 Biogen Anterior Horn Cell Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Biogen Main Business Overview
11.13.5 Biogen Latest Developments
11.14 Orphazyme
11.14.1 Orphazyme Company Information
11.14.2 Orphazyme Anterior Horn Cell Disease Treatment Product Offered
11.14.3 Orphazyme Anterior Horn Cell Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Orphazyme Main Business Overview
11.14.5 Orphazyme Latest Developments
11.15 KRIGLE PHARMA, INC
11.15.1 KRIGLE PHARMA, INC Company Information
11.15.2 KRIGLE PHARMA, INC Anterior Horn Cell Disease Treatment Product Offered
11.15.3 KRIGLE PHARMA, INC Anterior Horn Cell Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 KRIGLE PHARMA, INC Main Business Overview
11.15.5 KRIGLE PHARMA, INC Latest Developments
11.16 Aquestive Therapeutics, Inc
11.16.1 Aquestive Therapeutics, Inc Company Information
11.16.2 Aquestive Therapeutics, Inc Anterior Horn Cell Disease Treatment Product Offered
11.16.3 Aquestive Therapeutics, Inc Anterior Horn Cell Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Aquestive Therapeutics, Inc Main Business Overview
11.16.5 Aquestive Therapeutics, Inc Latest Developments
11.17 Apotex Inc
11.17.1 Apotex Inc Company Information
11.17.2 Apotex Inc Anterior Horn Cell Disease Treatment Product Offered
11.17.3 Apotex Inc Anterior Horn Cell Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Apotex Inc Main Business Overview
11.17.5 Apotex Inc Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Anterior Horn Cell Disease Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Riluzole
Table 3. Major Players of Edaravone
Table 4. Major Players of Glutamate Receptor Antagonist
Table 5. Major Players of Other
Table 6. Anterior Horn Cell Disease Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Anterior Horn Cell Disease Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Anterior Horn Cell Disease Treatment Market Size Market Share by Type (2017-2022)
Table 9. Anterior Horn Cell Disease Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Anterior Horn Cell Disease Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Anterior Horn Cell Disease Treatment Market Size Market Share by Application (2017-2022)
Table 12. Global Anterior Horn Cell Disease Treatment Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Anterior Horn Cell Disease Treatment Revenue Market Share by Player (2020-2022)
Table 14. Anterior Horn Cell Disease Treatment Key Players Head office and Products Offered
Table 15. Anterior Horn Cell Disease Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Anterior Horn Cell Disease Treatment Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Anterior Horn Cell Disease Treatment Market Size Market Share by Regions (2017-2022)
Table 20. Americas Anterior Horn Cell Disease Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Anterior Horn Cell Disease Treatment Market Size Market Share by Country (2017-2022)
Table 22. Americas Anterior Horn Cell Disease Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Anterior Horn Cell Disease Treatment Market Size Market Share by Type (2017-2022)
Table 24. Americas Anterior Horn Cell Disease Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Anterior Horn Cell Disease Treatment Market Size Market Share by Application (2017-2022)
Table 26. APAC Anterior Horn Cell Disease Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Anterior Horn Cell Disease Treatment Market Size Market Share by Region (2017-2022)
Table 28. APAC Anterior Horn Cell Disease Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Anterior Horn Cell Disease Treatment Market Size Market Share by Type (2017-2022)
Table 30. APAC Anterior Horn Cell Disease Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Anterior Horn Cell Disease Treatment Market Size Market Share by Application (2017-2022)
Table 32. Europe Anterior Horn Cell Disease Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Anterior Horn Cell Disease Treatment Market Size Market Share by Country (2017-2022)
Table 34. Europe Anterior Horn Cell Disease Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Anterior Horn Cell Disease Treatment Market Size Market Share by Type (2017-2022)
Table 36. Europe Anterior Horn Cell Disease Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Anterior Horn Cell Disease Treatment Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Anterior Horn Cell Disease Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Anterior Horn Cell Disease Treatment Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Anterior Horn Cell Disease Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Anterior Horn Cell Disease Treatment Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Anterior Horn Cell Disease Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Anterior Horn Cell Disease Treatment Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Anterior Horn Cell Disease Treatment
Table 45. Key Market Challenges & Risks of Anterior Horn Cell Disease Treatment
Table 46. Key Industry Trends of Anterior Horn Cell Disease Treatment
Table 47. Global Anterior Horn Cell Disease Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Anterior Horn Cell Disease Treatment Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Anterior Horn Cell Disease Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Anterior Horn Cell Disease Treatment Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Anterior Horn Cell Disease Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Anterior Horn Cell Disease Treatment Market Size Market Share Forecast by Application (2023-2028)
Table 53. Sanofi Details, Company Type, Anterior Horn Cell Disease Treatment Area Served and Its Competitors
Table 54. Sanofi Anterior Horn Cell Disease Treatment Product Offered
Table 55. Sanofi Anterior Horn Cell Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Sanofi Main Business
Table 57. Sanofi Latest Developments
Table 58. Novartis AG Details, Company Type, Anterior Horn Cell Disease Treatment Area Served and Its Competitors
Table 59. Novartis AG Anterior Horn Cell Disease Treatment Product Offered
Table 60. Novartis AG Main Business
Table 61. Novartis AG Anterior Horn Cell Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Novartis AG Latest Developments
Table 63. Mitsubishi Chemical Group Corporation Details, Company Type, Anterior Horn Cell Disease Treatment Area Served and Its Competitors
Table 64. Mitsubishi Chemical Group Corporation Anterior Horn Cell Disease Treatment Product Offered
Table 65. Mitsubishi Chemical Group Corporation Main Business
Table 66. Mitsubishi Chemical Group Corporation Anterior Horn Cell Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Mitsubishi Chemical Group Corporation Latest Developments
Table 68. BrainStorm Cell Limited Details, Company Type, Anterior Horn Cell Disease Treatment Area Served and Its Competitors
Table 69. BrainStorm Cell Limited Anterior Horn Cell Disease Treatment Product Offered
Table 70. BrainStorm Cell Limited Main Business
Table 71. BrainStorm Cell Limited Anterior Horn Cell Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. BrainStorm Cell Limited Latest Developments
Table 73. Ionis Pharmaceuticals Details, Company Type, Anterior Horn Cell Disease Treatment Area Served and Its Competitors
Table 74. Ionis Pharmaceuticals Anterior Horn Cell Disease Treatment Product Offered
Table 75. Ionis Pharmaceuticals Main Business
Table 76. Ionis Pharmaceuticals Anterior Horn Cell Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Ionis Pharmaceuticals Latest Developments
Table 78. Genervon Biopharmaceuticals, LLC Details, Company Type, Anterior Horn Cell Disease Treatment Area Served and Its Competitors
Table 79. Genervon Biopharmaceuticals, LLC Anterior Horn Cell Disease Treatment Product Offered
Table 80. Genervon Biopharmaceuticals, LLC Main Business
Table 81. Genervon Biopharmaceuticals, LLC Anterior Horn Cell Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Genervon Biopharmaceuticals, LLC Latest Developments
Table 83. Bausch Health Companies Inc Details, Company Type, Anterior Horn Cell Disease Treatment Area Served and Its Competitors
Table 84. Bausch Health Companies Inc Anterior Horn Cell Disease Treatment Product Offered
Table 85. Bausch Health Companies Inc Main Business
Table 86. Bausch Health Companies Inc Anterior Horn Cell Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Bausch Health Companies Inc Latest Developments
Table 88. F. Hoffmann-La Roche Ltd Details, Company Type, Anterior Horn Cell Disease Treatment Area Served and Its Competitors
Table 89. F. Hoffmann-La Roche Ltd Anterior Horn Cell Disease Treatment Product Offered
Table 90. F. Hoffmann-La Roche Ltd Main Business
Table 91. F. Hoffmann-La Roche Ltd Anterior Horn Cell Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. F. Hoffmann-La Roche Ltd Latest Developments
Table 93. Treeway B.V Details, Company Type, Anterior Horn Cell Disease Treatment Area Served and Its Competitors
Table 94. Treeway B.V Anterior Horn Cell Disease Treatment Product Offered
Table 95. Treeway B.V Main Business
Table 96. Treeway B.V Anterior Horn Cell Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. Treeway B.V Latest Developments
Table 98. CYTOKINETICS Details, Company Type, Anterior Horn Cell Disease Treatment Area Served and Its Competitors
Table 99. CYTOKINETICS Anterior Horn Cell Disease Treatment Product Offered
Table 100. CYTOKINETICS Main Business
Table 101. CYTOKINETICS Anterior Horn Cell Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 102. CYTOKINETICS Latest Developments
Table 103. AB Science Details, Company Type, Anterior Horn Cell Disease Treatment Area Served and Its Competitors
Table 104. AB Science Anterior Horn Cell Disease Treatment Product Offered
Table 105. AB Science Anterior Horn Cell Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 106. AB Science Main Business
Table 107. AB Science Latest Developments
Table 108. ADVANZ PHARMA Details, Company Type, Anterior Horn Cell Disease Treatment Area Served and Its Competitors
Table 109. ADVANZ PHARMA Anterior Horn Cell Disease Treatment Product Offered
Table 110. ADVANZ PHARMA Main Business
Table 111. ADVANZ PHARMA Anterior Horn Cell Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 112. ADVANZ PHARMA Latest Developments
Table 113. Biogen Details, Company Type, Anterior Horn Cell Disease Treatment Area Served and Its Competitors
Table 114. Biogen Anterior Horn Cell Disease Treatment Product Offered
Table 115. Biogen Main Business
Table 116. Biogen Anterior Horn Cell Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 117. Biogen Latest Developments
Table 118. Orphazyme Details, Company Type, Anterior Horn Cell Disease Treatment Area Served and Its Competitors
Table 119. Orphazyme Anterior Horn Cell Disease Treatment Product Offered
Table 120. Orphazyme Main Business
Table 121. Orphazyme Anterior Horn Cell Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 122. Orphazyme Latest Developments
Table 123. KRIGLE PHARMA, INC Details, Company Type, Anterior Horn Cell Disease Treatment Area Served and Its Competitors
Table 124. KRIGLE PHARMA, INC Anterior Horn Cell Disease Treatment Product Offered
Table 125. KRIGLE PHARMA, INC Main Business
Table 126. KRIGLE PHARMA, INC Anterior Horn Cell Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 127. KRIGLE PHARMA, INC Latest Developments
Table 128. Aquestive Therapeutics, Inc Details, Company Type, Anterior Horn Cell Disease Treatment Area Served and Its Competitors
Table 129. Aquestive Therapeutics, Inc Anterior Horn Cell Disease Treatment Product Offered
Table 130. Aquestive Therapeutics, Inc Main Business
Table 131. Aquestive Therapeutics, Inc Anterior Horn Cell Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 132. Aquestive Therapeutics, Inc Latest Developments
Table 133. Apotex Inc Details, Company Type, Anterior Horn Cell Disease Treatment Area Served and Its Competitors
Table 134. Apotex Inc Anterior Horn Cell Disease Treatment Product Offered
Table 135. Apotex Inc Main Business
Table 136. Apotex Inc Anterior Horn Cell Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 137. Apotex Inc Latest Developments
List of Figures
List of Figures
Figure 1. Anterior Horn Cell Disease Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anterior Horn Cell Disease Treatment Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Anterior Horn Cell Disease Treatment Market Size Market Share by Type in 2021
Figure 7. Anterior Horn Cell Disease Treatment in Amyotrophic Lateral Sclerosis
Figure 8. Global Anterior Horn Cell Disease Treatment Market: Amyotrophic Lateral Sclerosis (2017-2022) & ($ Millions)
Figure 9. Anterior Horn Cell Disease Treatment in Spinal Muscular Atrophy
Figure 10. Global Anterior Horn Cell Disease Treatment Market: Spinal Muscular Atrophy (2017-2022) & ($ Millions)
Figure 11. Anterior Horn Cell Disease Treatment in Multifocal Motor Neuropathy
Figure 12. Global Anterior Horn Cell Disease Treatment Market: Multifocal Motor Neuropathy (2017-2022) & ($ Millions)
Figure 13. Anterior Horn Cell Disease Treatment in Other
Figure 14. Global Anterior Horn Cell Disease Treatment Market: Other (2017-2022) & ($ Millions)
Figure 15. Global Anterior Horn Cell Disease Treatment Market Size Market Share by Application in 2021
Figure 16. Global Anterior Horn Cell Disease Treatment Revenue Market Share by Player in 2021
Figure 17. Global Anterior Horn Cell Disease Treatment Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Anterior Horn Cell Disease Treatment Market Size 2017-2022 ($ Millions)
Figure 19. APAC Anterior Horn Cell Disease Treatment Market Size 2017-2022 ($ Millions)
Figure 20. Europe Anterior Horn Cell Disease Treatment Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Anterior Horn Cell Disease Treatment Market Size 2017-2022 ($ Millions)
Figure 22. Americas Anterior Horn Cell Disease Treatment Value Market Share by Country in 2021
Figure 23. Americas Anterior Horn Cell Disease Treatment Consumption Market Share by Type in 2021
Figure 24. Americas Anterior Horn Cell Disease Treatment Market Size Market Share by Application in 2021
Figure 25. United States Anterior Horn Cell Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Anterior Horn Cell Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Anterior Horn Cell Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Anterior Horn Cell Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Anterior Horn Cell Disease Treatment Market Size Market Share by Region in 2021
Figure 30. APAC Anterior Horn Cell Disease Treatment Market Size Market Share by Application in 2021
Figure 31. China Anterior Horn Cell Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Anterior Horn Cell Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Anterior Horn Cell Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Anterior Horn Cell Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Anterior Horn Cell Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Anterior Horn Cell Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Anterior Horn Cell Disease Treatment Market Size Market Share by Country in 2021
Figure 38. Europe Anterior Horn Cell Disease Treatment Market Size Market Share by Type in 2021
Figure 39. Europe Anterior Horn Cell Disease Treatment Market Size Market Share by Application in 2021
Figure 40. Germany Anterior Horn Cell Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Anterior Horn Cell Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Anterior Horn Cell Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Anterior Horn Cell Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Anterior Horn Cell Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Anterior Horn Cell Disease Treatment Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Anterior Horn Cell Disease Treatment Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Anterior Horn Cell Disease Treatment Market Size Market Share by Application in 2021
Figure 48. Egypt Anterior Horn Cell Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Anterior Horn Cell Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Anterior Horn Cell Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Anterior Horn Cell Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Anterior Horn Cell Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Anterior Horn Cell Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 54. APAC Anterior Horn Cell Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 55. Europe Anterior Horn Cell Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Anterior Horn Cell Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 57. United States Anterior Horn Cell Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 58. Canada Anterior Horn Cell Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Anterior Horn Cell Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Anterior Horn Cell Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 61. China Anterior Horn Cell Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 62. Japan Anterior Horn Cell Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 63. Korea Anterior Horn Cell Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Anterior Horn Cell Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 65. India Anterior Horn Cell Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 66. Australia Anterior Horn Cell Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 67. Germany Anterior Horn Cell Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 68. France Anterior Horn Cell Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 69. UK Anterior Horn Cell Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 70. Italy Anterior Horn Cell Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 71. Russia Anterior Horn Cell Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 72. Spain Anterior Horn Cell Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Anterior Horn Cell Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Anterior Horn Cell Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 75. Israel Anterior Horn Cell Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Anterior Horn Cell Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Anterior Horn Cell Disease Treatment Market Size 2023-2028 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets